Figure 4From: Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany Cost effectiveness acceptability curves, showing the probability of the 5-grass tablet and allergoid mix being most cost-effective at a range of willingness to pay thresholds. Back to article page